Based on the very limited data available from the article, pembrolizumab looks like a potentially perfect drug to pair with BIT225.
With pembrolizumab strengthening the T cells and BIT225 unmasking HIV, it looks like a winning combination.
Let us hope their Trial goes well. With it underway at this time alongside Biotron's trials, their timing is impeccable.
I would like to also thank the Americans for scaring out the weak hands with their financial news, as I managed to pick up a nice parcel during the dip.
covid news, page-126
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $6.308K | 311.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1673695 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 93000 | 2 |
View Market Depth
| Last trade - 15.39pm 08/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |